Latest News of ZLAB
Analyst Estimates: Here's What Brokers Think Of Zai Lab Limited (NASDAQ:ZLAB) After Its Third-Quarter Report
By Yahoo! Finance |
1 week ago
Zai Lab Limited (NASDAQ:ZLAB) shares dropped 13% to US$26.67 after its quarterly report. Analysts forecast a 64% revenue increase in 2025, with losses expected to decrease....
Zai Lab Ltd (ZLAB) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Path to Profitability
By Yahoo! Finance |
1 week ago
VYVGART has shown steady growth with 1,000 new patients monthly, focusing on transitioning to maintenance settings. Expectations for the fourth quarter remain strong, potentially leading to significan...
Zai Lab Limited (ZLAB) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance |
1 month ago
Zai Lab will showcase preclinical data of ZL-1503, a novel IL-13/IL-31 bispecific antibody for atopic dermatitis, at EADV Congress 2024. The presentation will cover the antibody's efficacy in treating...
-
Zai Lab Limited (ZLAB): Top ADR Stock According to Hedge Funds
By Yahoo! Finance | 2 months agoA list of Top 10 ADR Stocks To Buy by Hedge Funds features Zai Lab Limited (ZLAB) among other ADR stocks, emphasizing the importance of diversifying investments globally....
-
Insider Selling: Chairperson & CEO Ying Du Sells Shares of Zai Lab Ltd (ZLAB)
By Yahoo! Finance | 4 months agoZai Lab Ltd is a biopharmaceutical company focused on innovative medicines for cancer, autoimmune, and infectious diseases. Recent insider selling trends, with 21 sells and 3 buys in the past year, al...
-
Increases to CEO Compensation Might Be Put On Hold For Now at Zai Lab Limited (NASDAQ:ZLAB)
By Yahoo! Finance | 5 months agoZai Lab Limited has faced an 88% loss to shareholders in three years, despite a 23% growth in EPS. Concerns have arisen about the divergence between share price and fundamentals, leading shareholders ...